Mouse models for studying HCV vaccines and therapeutic antibodies

Jenna M. Gaska, Qiang Ding, Alexander Ploss

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations


In spite of the immense progress in hepatitis C virus (HCV) research, efforts to prevent infection, such as generating a vaccine, have not yet been successful. The high price tag associated with current treatment options for chronic infection and the spike in new infections concurrent with growing opioid abuse are strong motivators for developing effective immunization and understanding neutralizing antibodies’ role in preventing infection. Humanized mice—both human liver chimeras as well as genetically humanized models—are important platforms for testing both possible vaccine candidates as well as antibody-based therapies. This chapter details the variety of ways humanized mouse technology can be employed in pursuit of learning how HCV infection can be prevented.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Number of pages23
StatePublished - 2019

Publication series

NameMethods in Molecular Biology
ISSN (Print)1064-3745

All Science Journal Classification (ASJC) codes

  • Genetics
  • Molecular Biology


  • Hepatitis C virus
  • Humanized mice
  • Immunization
  • Neutralizing antibodies


Dive into the research topics of 'Mouse models for studying HCV vaccines and therapeutic antibodies'. Together they form a unique fingerprint.

Cite this